Inhibitory effects of FKBP14 on human cervical cancer cells.

In conclusion, FKBP14 may act as an oncogene through suppressing apoptosis and promoting motility in human cervical carcinogenesis; therefore, it may be considered a potential therapeutic target for the treatment of cervical cancer. PMID: 28731139 [PubMed - as supplied by publisher] (Source: Molecular Medicine Reports)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uLOGhT
via IFTTT